Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119184) titled 'Kuanxiong Aerosol Preconditioning Reduces Perioperative Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Condition:
Unstable Angina
Intervention:
Experimental group:Based on the standardized drug treatment recommended in the guideline (such as dual antiplatelet therapy, statins, beta-blockers, ACEI/ARB, etc.), 2 puffs (approximately 0.6 mL) of the broad chest inhalation aerosol (produced ...